COMPASS THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2018 | — | $-34.6K | — |
| Jun 2018 | — | $-43.0K | $7.2K |
| Sep 2018 | — | $-51.6K | $2.4K |
| Dec 2018 | — | $-84.8M | $4.7K |
| Mar 2019 | — | $-95.3M | $4.9K |
| Jun 2019 | — | $-103.9M | $4.9K |
| Sep 2019 | — | $-112.2M | $882 |
| Dec 2019 | $9.3M | $11.3M | $25.3M |
| Mar 2020 | — | $-124.8M | $3.7K |
| Jun 2020 | $5.6M | $53.3M | $65.4M |
| Sep 2020 | $3.7M | $47.3M | $55.5M |
| Dec 2020 | $1.9M | $39.9M | $47.1M |
| Mar 2021 | — | $33.5M | $39.7M |
| Jun 2021 | $0 | $28.9M | $31.2M |
| Sep 2021 | $0 | $23.9M | $25.5M |
| Dec 2021 | $0 | $140.1M | $144.5M |
| Mar 2022 | — | $134.5M | $136.4M |
| Jun 2022 | — | $126.9M | $26.2M |
| Sep 2022 | — | $116.1M | $16.5M |
| Dec 2022 | — | $181.6M | $34.9M |
| Mar 2023 | — | $175.3M | $27.0M |
| Jun 2023 | — | $168.3M | $19.3M |
| Sep 2023 | — | $160.0M | $30.4M |
| Dec 2023 | — | $148.5M | $24.2M |
| Mar 2024 | — | $157.1M | $43.5M |
| Jun 2024 | — | $146.1M | $19.4M |
| Sep 2024 | — | $138.4M | $19.4M |
| Dec 2024 | — | $125.2M | $43.5M |
| Mar 2025 | — | $110.3M | $41.0M |
| Jun 2025 | — | $93.2M | $22.9M |
| Sep 2025 | — | $209.6M | $46.2M |
| Dec 2025 | — | $196.8M | $30.6M |
| Mar 2026 | — | $186.5M | $55.2M |
| Jun 2026 | — | $166.0M | $35.5M |